GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR |
17.4119 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP2, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TYR |
16.5108 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, PPARA, PTGS2, RORC, SLC6A4, SRC, STAT3, TEK, TYR |
16.2663 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
13.9696 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, ATP1A1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FLT3, PTGS2, RORC, SLC6A4, SRC, STAT3, TEK, TYR |
13.6928 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, IGF1R, INSR, KIT, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, STAT3, TEK |
13.6928 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
13.2653 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
13.2533 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSD11B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, KIT, MET, PPARA, PTGS2, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
13.003 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
12.1022 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
12.0787 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SLC6A4, SMAD3, SRC, STAT3, TERT |
11.9927 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
11.7454 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
11.1591 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, ATP1A1, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, HSD17B2, IDO1, IGF1R, INSR, KCNH2, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TYR |
11.0274 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AURKB, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR |
10.9233 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AKR1C3, ALPL, ATP1A1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, KIT, PPARA, PTGS2, SLC6A4, SRC, STAT3, TEK |
10.8739 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B2, KIT, MET, PPARA, PTGS2 |
10.8731 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
10.7064 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, GSK3B, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
10.1844 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
10.1781 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, ATP1A1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, PTGS2, RORC, SLC6A4, SRC, STAT3, TYR |
10.1781 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MMP2, PTGS2, RORC, SLC6A4, SMAD3, SRC, STAT3 |
9.97875 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AKR1C3, ALPL, APP, ATP1A1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MMP2, MMP9, NUAK1, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TERT |
9.87802 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, ATP1A1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT |
9.87802 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
9.80579 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, STAT3, TEK, TERT |
9.67735 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AKR1C3, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, STAT3, TEK, TERT |
9.4656 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
9.4656 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
9.4656 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, STAT3, TEK, TERT |
9.42935 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, ATP1A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, STAT3, TEK, TERT |
9.4111 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
9.39031 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, ATP1A1, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC, STAT3 |
9.36761 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
9.34878 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, STAT3, TEK, TERT |
9.23202 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NUAK1, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
9.19258 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, ESR1, HSD11B1, HSD17B2 |
9.18646 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, FABP3, FUT7, HSPA1A, IDO1, PIM1, PPARA, PTGS2, TYR, XDH |
9.06356 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT |
8.94463 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, DRD1, DRD5, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, KIT, MMP2, PTGS2, SLC6A4, SMAD3, SRC, STAT3 |
8.8984 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT |
8.83417 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
8.75102 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
8.74739 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AURKB, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
8.5039 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DHFR, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.39256 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, ATP1A1, AXL, CA9, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, KCNH2, KDR, PTGS2, SLC6A2, SLC6A4, SRC, STAT3 |
8.37076 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, ATP1A1, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MET, SMAD3, SRC, STAT3, TERT |
8.30638 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, INSR, KDR, KIT, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR |
8.30638 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KIT, MET, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
8.25626 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
8.2289 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, AKR1C3, ATP1A1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, KIT, PPARA, PTGS2, RORC, SRC, TEK |
8.19711 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
8.17688 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
8.17688 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
8.17688 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
8.09533 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
8.09434 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
8.0862 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
8.08618 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
8.01645 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, EGFR, HSPA1A, IDO1 |
7.97145 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.88834 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, ATP1A1, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
7.81393 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, ATP1A1, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, KIT, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
7.79659 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, DRD3, EGFR, F3, INSR, KIT, MET, SRC, TEK, XDH |
7.77655 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.73786 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, ATP1A1, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, INSR, KCNH2, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
7.73345 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A4, SRC, TEK, TYR |
7.67242 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, AURKB, CDC25B, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, XDH |
7.64791 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
7.62325 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD11B1, HSD17B2, INSR, KDR, KIT, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, STAT3, TEK, TYR |
7.62325 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
7.54917 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.54892 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
7.54222 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, ATP1A1, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, SMAD3, STAT3 |
7.49172 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, XDH |
7.47854 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
7.43499 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT |
7.41374 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, ATP1A1, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
7.41362 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, ATP1A1, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HCAR2, HSPA1A, IDO1, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SMAD3, SRC, STAT3, TEK, TERT |
7.36295 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, GSK3B, HCAR2, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT |
7.36295 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, KIT, MET, PPARA, PTGS2 |
7.35946 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, PPARA, SMAD3, SRC, TEK, TYR |
7.31854 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS2 |
7.30429 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, KIT, PTGS2, SLC6A4 |
7.23481 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, KIT, PTGS2, SLC6A4 |
7.23481 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
7.1504 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
7.1504 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS2 |
7.05725 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, ATP1A1, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, GSK3B, HCAR2, HSPA1A, INSR, KCNH2, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT |
7.04938 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
7.02247 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.98446 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, INSR, PTGS2, SLC6A2, SLC6A4, SMAD3 |
6.97887 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
6.93505 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CSNK2A1, CYP2D6, DHFR, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, XDH |
6.92877 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CES1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, KDR, SLC6A4, SRC, STAT3 |
6.77957 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
6.73577 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, DRD1, DRD5, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, PTGS2, RORC, SLC6A4, SRC |
6.67703 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, GSK3B, KIT, PPARA, RORC, SLC6A4, SRC |
6.48213 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, AKR1C3, ATP1A1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD11B1, HSD17B2 |
6.44101 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS2 |
6.38689 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
6.38689 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, GSK3B, HSD11B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
6.34099 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, PPARA, PTGS2 |
6.31207 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, KIT, MMP2, MMP9, PTGS2, SLC6A4, SRC, STAT3 |
6.31207 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DHFR, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GSK3B, HSPA1A, INSR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
6.30552 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.28863 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD5, EGFR, GSK3B, HSPA1A, IDO1, KIT, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT |
6.23006 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2, SLC6A4 |
6.1449 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.13653 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.07948 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
6.07516 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, KIT, MMP9, PTGS2, TERT |
5.9877 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DHFR, DRD2, DRD5, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, INSR, KIT, PTPN1, SMAD3, SRC, STAT3, TEK, TERT, XDH |
5.96927 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, KDR, PTGS2, SRC, STAT3 |
5.95011 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, DRD5, PTGS2, SLC6A4 |
5.92901 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
5.91972 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.9079 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.89873 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.76491 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F3, INSR, KIT, MET, SRC, TEK |
5.75079 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, TYR |
5.73601 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, EGFR |
5.71878 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, STAT3, TEK |
5.71026 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT, PTGS2, SLC6A4 |
5.69721 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS2 |
5.69721 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, PTGS2, SLC6A4, SRC, TEK |
5.69721 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2, SMAD3, TEK |
5.69061 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, PPARA, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
5.56623 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, RORC |
5.5328 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, STAT3, TEK |
5.44075 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.42885 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, PTGS2, STAT3 |
5.4237 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TYR, XDH |
5.40633 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, STAT3, XDH |
5.40633 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
5.35608 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
5.35592 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC, STAT3 |
5.28826 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT, PTGS2, SLC6A4 |
5.2844 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, EGFR |
5.2557 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DHFR, DRD2, DRD5, EGFR, PPARA, SMAD3 |
5.2112 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.17248 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B2 |
5.09545 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
5.08134 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, IDO1, PPARA, PTGS2 |
5.08134 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CSNK2A1, CYP2D6, DHFR, DRD2, DRD3, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, XDH |
5.07232 |
[BP] GO:0050801 |
ion homeostasis
|
APP, ATP1A1, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, KCNH2, SMAD3 |
5.05176 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, XDH |
5.05176 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, EGFR, ESRRB, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
5.05176 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
5.04774 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
5.04407 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, STAT3, TEK |
5.02003 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, INSR, KIT, PTGS2 |
5.0113 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, XDH |
4.98571 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.94254 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
4.93272 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, KIT, MMP9, TERT |
4.92042 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9, PTGS2 |
4.90556 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GSK3B, HCAR2, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, STAT3, TEK |
4.86659 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, STAT3, TERT |
4.84754 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
4.84718 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, DRD2, EGFR, FLT3, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
4.80718 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, PTGS2, SLC6A4, SRC, TEK |
4.77774 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, ATP1A1, CA2, CA7, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9, PTGS2, SLC6A4 |
4.77774 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC |
4.76519 |
[BP] GO:0008217 |
None
|
ADORA1, ATP1A1, DRD2, DRD3, DRD5, PPARA, PTGS2, SMAD3 |
4.74249 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ATP1A1, DRD2, DRD3, EGFR, GPR35, HCAR2, KCNH2, KIT, PTGS2, SMAD3 |
4.74249 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS2 |
4.74195 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GSK3B, IDO1, INSR, KDR, KIT, NUAK1, PIM1, PPARA, PTGS2, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
4.73031 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
4.71576 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
4.64865 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
4.64481 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, RORC, SMAD3, SRC, STAT3, TERT |
4.63135 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AXL, CDC25B, CES1, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GSK3B, KDR, KIT, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, STAT3, TEK, TERT |
4.62725 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, IDO1, INSR, KIT, PPARA, PTGS2, SLC6A4, STAT3 |
4.56399 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
4.53276 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
4.53276 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, ATP1A1, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, KCNH2, SMAD3 |
4.52233 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
4.49464 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, GSK3B, IDO1, INSR, KDR, KIT, PIM1, PTGS2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
4.49464 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.48046 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
4.46503 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
4.44151 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD5, GSK3B |
4.42228 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC, STAT3, TERT |
4.40623 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, KIT, PTPN1, SRC, STAT3 |
4.39432 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, KIT |
4.37505 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, ESRRB, INSR, PPARA, STAT3 |
4.35102 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KCNH2, KIT, PTGS2, SLC6A4, SRC, TEK, TYR |
4.31144 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PTPN1, SRC, STAT3, TEK |
4.28885 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, STAT3, TEK, TERT |
4.27612 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
4.27612 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GSK3B, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
4.27612 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, ESRRB, INSR, PPARA, STAT3 |
4.26569 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC, STAT3 |
4.24894 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
4.22572 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC, TEK |
4.2042 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, PTGS2, SLC6A4 |
4.18562 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, PTGS2, SLC6A4 |
4.18562 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4, STAT3 |
4.18562 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA |
4.18058 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2, DRD3 |
4.16837 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, STAT3, TERT |
4.13384 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
4.13344 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, PTGS2, SRC |
4.12113 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, CYP1B1, DRD2, FABP3, HSPA1A, IDO1, PTGS2, SLC6A4, SMAD3, STAT3, TERT, XDH |
4.12085 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, DRD2, DRD3, EGFR, GSK3B, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC |
4.1194 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, DRD2, DRD3, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK |
4.11557 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.06725 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.06725 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
4.02743 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, PTGS2, SLC6A4 |
4.02595 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
4.00808 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, PTGS2, SLC6A4 |
4.00716 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
4.00233 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
4.00084 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.9877 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.9793 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
3.97606 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TERT |
3.97606 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AKR1C3, ATP1A1, EGFR, ESR1, FLT3, INSR, KIT, SRC, STAT3 |
3.97606 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.97112 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, GSK3B, PPARA, RORC, SLC6A4 |
3.96035 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.94005 |
[BP] GO:0055080 |
cation homeostasis
|
APP, ATP1A1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, KCNH2, SMAD3 |
3.93411 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3, KIT |
3.93411 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGS2, TYR |
3.92549 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.92231 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
3.9222 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, PTGS2, SMAD3, XDH |
3.85784 |
[BP] GO:0051241 |
negative regulation of multicellular organismal process
|
ADORA1, APP, ATP1A1, AXL, DRD2, DRD3, EGFR, GPR35, GSK3B, IDO1, PTGS2, SLC6A4, SMAD3, STAT3, TEK, TERT, XDH |
3.85397 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.83943 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, STAT3, TEK, XDH |
3.82947 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT |
3.81479 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC |
3.79683 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
3.79546 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KCNH2, KDR, PTGS2, SRC |
3.78128 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, DRD1, DRD5, EGFR, ESR1, KIT, PTGS2, SLC6A4, SRC |
3.77544 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, KIT, MET, PIM1, SRC, STAT3, TEK, TYR |
3.76326 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.76182 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, KIT, PTGS2, TYR |
3.74946 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.74718 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3, KIT |
3.7452 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, XDH |
3.74125 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
3.72346 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, CA2, CYP1B1, DRD2, ESRRB, F3, IDO1, INSR, KDR, KIT, PIM1, PTGS2, SMAD3, SRC, STAT3, TEK, TERT |
3.72246 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.71838 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, HSPA1A, INSR, KIT, MET, MMP12, PPARA, RORC, SLC6A4, SMAD3, SRC, STAT3, TERT |
3.70907 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, ATP1A1, CA2, EGFR, FLT3, PTGS2, SRC |
3.65077 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PTGS2, STAT3, TEK, TERT |
3.64528 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, DRD5, KIT, PTGS2 |
3.64528 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, STAT3, TEK |
3.63092 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.6233 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SLC6A4, SRC |
3.61384 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
3.61384 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AURKB, CSNK2A1, DHFR, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, XDH |
3.60553 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.60553 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.60553 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.60553 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.60553 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.60553 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.60553 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.5894 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, GSK3B, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3, STAT3 |
3.57819 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
3.5694 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, PTGS2 |
3.54525 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD17B2 |
3.47443 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, GSK3B, HSPA1A, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, STAT3, XDH |
3.46952 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, APP, DRD2, DRD3, GPR35, GSK3B, HSPA1A, KCNH2, MMP9, PTGS2 |
3.44898 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.44413 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.44256 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSD11B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
3.39979 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, STAT3, TEK, XDH |
3.38267 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.38019 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.37086 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.36615 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, KIT, PTPN1, SRC, STAT3 |
3.35092 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC, STAT3 |
3.33708 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, SRC |
3.33708 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, STAT3, TERT |
3.32913 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.32246 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, STAT3 |
3.32246 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.32246 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, DRD5 |
3.30987 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, STAT3, TEK, TERT, XDH |
3.28595 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT |
3.27085 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.27085 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET, STAT3 |
3.2585 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, IDO1 |
3.24144 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, IDO1, KIT, MMP12, MMP2, PTPN1, SMAD3, SRC, STAT3 |
3.22476 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.22476 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.22476 |
[BP] GO:1902893 |
None
|
PPARA, SMAD3, STAT3, TERT |
3.22476 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
3.20406 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, PPARA, STAT3 |
3.19012 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
3.16627 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
3.16627 |
[BP] GO:0007189 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
3.16627 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, PPARA, STAT3 |
3.16627 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
3.15348 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, EGFR, HCAR2, MET, PPARA, SMAD3, STAT3 |
3.14554 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.13724 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.13724 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
3.13714 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADRA2A, APP, CSNK2A1, DRD2, DRD3, DRD5, DUSP3, FABP4, GSK3B, IGF1R, MMP9, PTGS2, PTPN1, SRC |
3.12174 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, HSD11B1, HSD17B2 |
3.12174 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
3.12081 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, ATP1A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, KCNH2, SMAD3 |
3.12081 |
[BP] GO:0071383 |
None
|
AKR1C3, ATP1A1, EGFR, FLT3, SRC |
3.12081 |
[BP] GO:0040008 |
regulation of growth
|
APP, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A4, SMAD3, STAT3 |
3.11584 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
3.10122 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
3.0957 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, ADRA2A, AKR1C3, APP, ATP1A1, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GSK3B, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, STAT3, TERT |
3.09523 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, ALPL, CYP1A1, EGFR, PTGS2, SLC6A4, TYR |
3.09356 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
3.09356 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
3.09356 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, ATP1A1, DRD1, DRD2, DRD3, GPR35, KCNH2, PTGS2 |
3.08753 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT |
3.08665 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, CYP19A1, ESR1, HSD17B2, INSR, KIT, SRC |
3.08612 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.08612 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, ATP1A1, AXL, EGFR, ESR1, FLT3, RORC, SLC6A4, SRC |
3.08348 |
[BP] GO:1900371 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, STAT3 |
3.08286 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3 |
3.08114 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
3.0682 |
[BP] GO:0030808 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, STAT3 |
3.0682 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.06764 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT, STAT3 |
3.05891 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, CSNK2A1, DRD2, DRD3, EGFR, GSK3B, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC, TERT |
3.0573 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR, TERT |
3.05266 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
3.05266 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, APP, DRD2, DRD3, EGFR, GSK3B, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.05266 |
[BP] GO:0046960 |
None
|
DRD1, DRD5 |
3.05266 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
3.05266 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
3.05266 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
3.05266 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.05266 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
3.05266 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, TYR |
3.04562 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.03695 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT, STAT3 |
3.02074 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.01487 |
[BP] GO:0060158 |
None
|
DRD1, DRD2, DRD5 |
3.01487 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
3.01393 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
3.01393 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, ATP1A1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
3.00678 |
[BP] GO:0045833 |
None
|
ADORA1, ADRA2A, AKR1C3, ATP1A1, HCAR2 |
3.00147 |
[BP] GO:0097756 |
None
|
ADORA1, DRD5, PTGS2, SLC6A4 |
3.00077 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AURKB, CSNK2A1, DHFR, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, XDH |
2.9656 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
2.95835 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.95649 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ATP1A1, DRD2, EGFR, KCNH2, PTGS2 |
2.95649 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.95649 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3, STAT3 |
2.95649 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
2.93724 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
2.93576 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.93576 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.931 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.931 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.92948 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.92948 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, ATP1A1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.92857 |
[BP] GO:0051254 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT |
2.92136 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.89235 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, GSK3B, HCAR2, MMP12, PTGS2, SMAD3, SRC |
2.89202 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.87414 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.87414 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, APP, DRD2, DRD3, EGFR, GSK3B, HCAR2, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.85915 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, GSK3B, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.85915 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.85915 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.85915 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.85915 |
[BP] GO:0031327 |
None
|
ADRA2A, AKR1C3, ATP1A1, AURKB, DHFR, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC, STAT3 |
2.85666 |
[BP] GO:0007200 |
None
|
ADRA2A, DRD1, DRD2, DRD5, ESR1 |
2.85666 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.85314 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MMP1, MMP12, MMP9, SRC, TEK |
2.80721 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.7967 |
[BP] GO:0045862 |
positive regulation of proteolysis
|
ADRA2A, APP, F3, GSK3B, HSPA1A, SMAD3, SRC, STAT3, XDH |
2.7967 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, GSK3B, PTGS2, SMAD3, SRC, TERT |
2.79221 |
[BP] GO:0009890 |
None
|
ADRA2A, AKR1C3, ATP1A1, AURKB, DHFR, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC, STAT3 |
2.79193 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD5 |
2.79155 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.79155 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.79155 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.77527 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.77527 |
[BP] GO:0019933 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.77527 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.77527 |
[BP] GO:0052548 |
None
|
APP, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, STAT3, XDH |
2.7721 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, APP, AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MMP1, MMP12, MMP9, PTGS2, SRC, STAT3, TEK |
2.76807 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, DHFR, SLC6A4 |
2.76091 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, KIT, PTPN1, SRC |
2.75418 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, FABP3, FABP4, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.74705 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.74303 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, DRD3, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.73114 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, EGFR, FLT3, PTGS2, SRC |
2.71642 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, AKR1C3, ALPL, ATP1A1, AXL, CYP1A1, CYP1A2, DRD3, EGFR, IDO1, KIT, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TYR |
2.70772 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, EGFR, INSR, KIT, PTPN1, SRC |
2.70603 |
[BP] GO:0045595 |
regulation of cell differentiation
|
APP, AXL, CA2, DRD2, DRD3, EGFR, ESRRA, ESRRB, GSK3B, KDR, KIT, PPARA, PTGS2, RORC, SLC6A4, SMAD3, STAT3, TERT, XDH |
2.70446 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.70446 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.69959 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, XDH |
2.68977 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.68607 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1C3, APP, ATP1A1, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
2.68079 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, DRD2, EGFR, GSK3B, HCAR2, MMP12, PTGS2, SMAD3, SRC |
2.68079 |
[BP] GO:0045893 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT |
2.67506 |
[BP] GO:1903508 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT |
2.67506 |
[BP] GO:1902680 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT |
2.67211 |
[BP] GO:2000351 |
None
|
AKR1C3, KDR, TEK, TERT |
2.6689 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.66515 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.66515 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.66277 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.66277 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.66277 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.66277 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.66277 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.6621 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, EGFR, KDR |
2.6621 |
[BP] GO:0030817 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.65524 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, KCNH2 |
2.65524 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.65524 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.65392 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.65176 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 |
2.65152 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.63962 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, CES1, CYP19A1, DHFR, TYR |
2.63962 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.63962 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, KIT, PTGS2, TYR |
2.62393 |
[BP] GO:0019935 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.62096 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA2A, AKR1C3, APP, CA2, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, GSK3B, HCAR2, INSR, SRC |
2.61447 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, CSNK2A1, DRD1, DRD2, DRD3, EGFR, GSK3B, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.61316 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.60707 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.60707 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.60707 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.60707 |
[BP] GO:0052547 |
None
|
APP, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, STAT3, XDH |
2.60087 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.59842 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.59842 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.59842 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.59842 |
[BP] GO:0050678 |
None
|
EGFR, F3, KDR, MMP12, SMAD3, STAT3, TEK, XDH |
2.59786 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.59786 |
[BP] GO:0007617 |
None
|
APP, DRD1, DRD5 |
2.59786 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR |
2.59412 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, KIT, PTGS2, SLC6A4, TYR |
2.57599 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, SRC, TEK |
2.57589 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.57589 |
[BP] GO:0006811 |
None
|
ATP1A1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, FABP3, KCNH2, PPARA, SLC6A2, SLC6A4 |
2.57457 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, CYP1A1, EGFR, PTGS2, SLC6A4, SRC, TYR |
2.565 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, ATP1A1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.55078 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.54348 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.54348 |
[BP] GO:0007613 |
None
|
DRD1, DRD2, INSR, PTGS2, SLC6A4 |
2.54225 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.53999 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.53999 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.52587 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX5, CES1, CYP19A1, CYP1A1, DHFR, IDO1, PTGS2 |
2.52127 |
[BP] GO:0034762 |
None
|
ADRA2A, APP, CA2, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
2.52127 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.52009 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.51412 |
[BP] GO:0045596 |
None
|
APP, DRD3, EGFR, ESRRB, GSK3B, PPARA, SLC6A4, SMAD3, STAT3, TERT, XDH |
2.49742 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, CYP19A1, ESR1, INSR, KIT |
2.49365 |
[BP] GO:0050679 |
None
|
EGFR, F3, KDR, MMP12, STAT3, TEK |
2.48989 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.48617 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.48617 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.48617 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.48617 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.48617 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, GSK3B, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.48605 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B2, PTGS2 |
2.48605 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MMP1, MMP12, MMP9, SRC, TEK |
2.47886 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.47081 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.47081 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.44081 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
2.43963 |
[BP] GO:1902895 |
None
|
SMAD3, STAT3, TERT |
2.43316 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.43316 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.43316 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.43316 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.42645 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.42645 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.42645 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.41698 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.41052 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.40533 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.40533 |
[BP] GO:1900544 |
None
|
DRD1, DRD5, ESRRB, INSR, STAT3 |
2.39058 |
[BP] GO:0045981 |
None
|
DRD1, DRD5, ESRRB, INSR, STAT3 |
2.39058 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.39058 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.38809 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.38809 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38809 |
[BP] GO:0030814 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.37722 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD5 |
2.37722 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD5 |
2.35107 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.33727 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.33727 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.33727 |
[BP] GO:0030802 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.33015 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, KIT, MMP9, RORC, SMAD3, SRC |
2.31485 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, CYP1A1, DRD3, EGFR, HSPA1A, IDO1, INSR, KDR, MET, MMP1, MMP12, SLC6A4, SMAD3, SRC, STAT3 |
2.31269 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, APP, CES1, CYP1B1, DHFR |
2.30645 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, STAT3 |
2.30454 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.2982 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.29102 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.29102 |
[BP] GO:0043467 |
regulation of generation of precursor metabolites and energy
|
ESRRB, GSK3B, INSR, PPARA, STAT3 |
2.28857 |
[BP] GO:0071229 |
cellular response to acid chemical
|
AKR1C3, EGFR, KDR, MMP2, SLC6A4, SRC |
2.28857 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.28619 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, KIT, PTGS2 |
2.28619 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, DRD2, GPR35, PTGS2 |
2.28619 |
[BP] GO:0045936 |
None
|
ADRA2A, DRD2, DRD3, DUSP3, FABP4, IGF1R, PPARA, PTPN1, STAT3, XDH |
2.27905 |
[BP] GO:0030162 |
regulation of proteolysis
|
ADRA2A, APP, CSNK2A1, F3, GSK3B, HSPA1A, MMP9, PTGS2, SMAD3, SRC, STAT3, XDH |
2.27452 |
[BP] GO:0010563 |
None
|
ADRA2A, DRD2, DRD3, DUSP3, FABP4, IGF1R, PPARA, PTPN1, STAT3, XDH |
2.27452 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
2.26579 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.26392 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.26171 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, EGFR, KDR, SRC, TEK |
2.25935 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, ATP1A1, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.25646 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.25646 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.25646 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.25646 |
[BP] GO:0006693 |
None
|
AKR1C3, CES2, PTGS2 |
2.25646 |
[BP] GO:0006692 |
None
|
AKR1C3, CES2, PTGS2 |
2.25646 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.25646 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TERT |
2.25646 |
[BP] GO:0051248 |
None
|
APP, CSNK2A1, DHFR, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MMP9, PTGS2, PTPN1, SMAD3, SRC, STAT3, XDH |
2.25646 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, DRD2, DRD3, STAT3 |
2.25646 |
[BP] GO:0006110 |
None
|
ESRRB, INSR, PPARA, STAT3 |
2.25646 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.25646 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.25646 |
[BP] GO:0099565 |
chemical synaptic transmission, postsynaptic
|
DRD2, GSK3B |
2.25646 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.25646 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.25646 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.25646 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.25646 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.25646 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.25646 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.25646 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.25646 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA2A, AKR1C3, ALOX5, APP, ATP1A1, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, EGFR, FABP3, HSPA1A, KCNH2, KIT, MMP12, MMP9, PPARA, SLC6A2, SLC6A4, SRC, STAT3, TERT, XDH |
2.25366 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
2.23881 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.23554 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.23554 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.22172 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, CYP1B1, ESR1, ESR2, HSPA1A, KIT, PIM1 |
2.20799 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA2A, AKR1C3, ALOX5, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, HSPA1A, KCNH2, KIT, MMP12, MMP9, PPARA, SLC6A2, SLC6A4, SRC, STAT3, TERT, XDH |
2.20799 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, ADRA2A, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, STAT3, TERT |
2.1946 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.1946 |
[BP] GO:0045934 |
None
|
ADRA2A, AURKB, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT |
2.19408 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, PTGS2, SLC6A4, TEK, TYR |
2.19408 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.19408 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.19408 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.1804 |
[BP] GO:0051345 |
None
|
APP, EGFR, ESR1, F3, GSK3B, HSPA1A, KIT, PTPN1, SMAD3, STAT3, XDH |
2.17881 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.17742 |
[BP] GO:0007154 |
None
|
ADORA1, AKR1C3, ATP1A1, AXL, DRD1, DRD2, DRD3, DRD5, ESR2, PTGS2, SLC6A2, TEK |
2.16841 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.16585 |
[BP] GO:0001817 |
regulation of cytokine production
|
ADRA2A, AXL, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.16585 |
[BP] GO:0031331 |
positive regulation of cellular catabolic process
|
ADRA2A, ESRRB, GSK3B, HSPA1A, INSR, KDR, PPARA, PTPN1 |
2.16585 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GSK3B, IGF1R, INSR, SRC |
2.16585 |
[BP] GO:0045765 |
regulation of angiogenesis
|
CYP1B1, F3, KDR, PTGS2, STAT3, TEK, TERT |
2.15951 |
[BP] GO:0001936 |
None
|
F3, KDR, STAT3, TEK, XDH |
2.15622 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.14607 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.14464 |
[BP] GO:0019098 |
None
|
APP, DRD1, DRD5 |
2.14464 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, APP |
2.14464 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT |
2.13809 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13658 |
[BP] GO:0042391 |
None
|
ADORA1, APP, ATP1A1, DRD1, GPR35, KCNH2, KDR, SRC |
2.13648 |
[BP] GO:0031099 |
regeneration
|
AXL, CSNK2A1, DHFR, EGFR, FLT3 |
2.119 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, APP, PTPN1 |
2.119 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, DRD2, EGFR, FABP3, FABP4, KIT, MET |
2.119 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.119 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.119 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.119 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.119 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A4 |
2.119 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A4 |
2.119 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A4 |
2.119 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A4 |
2.119 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.119 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.119 |
[BP] GO:0046958 |
None
|
DRD1, DRD5 |
2.119 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.11838 |
[BP] GO:0070873 |
None
|
ESRRB, GSK3B, INSR |
2.11838 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.11838 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.11838 |
[BP] GO:0031667 |
response to nutrient levels
|
AKR1C3, ALPL, CYP1A1, EGFR, PTGS2, SLC6A4, SRC, TYR |
2.11696 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.11402 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.11402 |
[BP] GO:0010629 |
None
|
APP, AURKB, DHFR, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, KDR, MMP12, PPARA, RORC, SMAD3, SRC, STAT3, TERT, XDH |
2.11402 |
[BP] GO:0043470 |
None
|
ESRRB, INSR, PPARA, STAT3 |
2.11164 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, APP, ATP1A1, AXL, DRD2, DRD3, SLC6A2, SLC6A4 |
2.11164 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.1052 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, DRD2, DRD3 |
2.09283 |
[BP] GO:1904035 |
regulation of epithelial cell apoptotic process
|
AKR1C3, KDR, TEK, TERT |
2.09283 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.09283 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.09283 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SLC6A4, SMAD3, SRC, TEK |
2.08931 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.08584 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, DRD5 |
2.08584 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.08584 |
[BP] GO:2000352 |
None
|
KDR, TEK, TERT |
2.08584 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, PPARA |
2.08584 |
[BP] GO:0042060 |
None
|
DRD5, EGFR, PPARA, SMAD3 |
2.07584 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, DRD2, DRD3, INSR, PIM1, SLC6A4, STAT3 |
2.07274 |
[BP] GO:0006357 |
None
|
APP, AURKB, CA9, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, KIT, MET, MMP12, PPARA, RORC, SMAD3, STAT3, TERT |
2.06319 |
[BP] GO:0030799 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.06034 |
[BP] GO:0032412 |
None
|
ADRA2A, APP, DRD2, DRD3, GPR35, MMP9 |
2.05216 |
[BP] GO:0030154 |
cell differentiation
|
AKR1C3, ALPL, AXL, CES1, CYP1A1, ESR1, FABP4, FLT3, FUT7, GSK3B, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SMAD3, STAT3 |
2.05216 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3 |
2.05146 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.05146 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.05146 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB |
2.05041 |
[BP] GO:0051093 |
None
|
APP, DRD3, EGFR, ESRRB, GSK3B, PPARA, SLC6A4, SMAD3, STAT3, TEK, TERT, XDH |
2.04755 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, PTGS2, SRC |
2.04336 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.0414 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.02694 |
[BP] GO:0070542 |
None
|
AKR1C3, FABP3, PTGS2, SRC |
2.02222 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.01722 |
[BP] GO:0032885 |
regulation of polysaccharide biosynthetic process
|
ESRRB, GSK3B, INSR |
2.01722 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, KIT |
2.01722 |
[BP] GO:0014074 |
response to purine-containing compound
|
APP, PTGS2, SLC6A4, TEK, TYR |
2.01527 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD5, EGFR |
2.01527 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
2.00951 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00951 |
[BP] GO:0043255 |
regulation of carbohydrate biosynthetic process
|
ESRRB, GSK3B, INSR, PPARA |
2.00951 |
[BP] GO:0000122 |
None
|
AURKB, DRD3, ESR1, ESR2, ESRRA, HSPA1A, MMP12, PPARA, RORC, SMAD3, STAT3 |
2.00951 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6 |
2.00951 |
[BP] GO:0098810 |
None
|
SLC6A2, SLC6A4 |
2.00951 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2D6 |
2.00951 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2D6 |
2.00951 |
[BP] GO:0022898 |
None
|
ADRA2A, APP, DRD2, DRD3, GPR35, MMP9 |
2.00951 |
[BP] GO:0090257 |
None
|
ADORA1, ADRA2A, ATP1A1, KIT, PTGS2, SMAD3 |
2.00951 |
[BP] GO:0034765 |
None
|
ADRA2A, APP, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
2.00392 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, ATP1A1, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.0033 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, APP, ATP1A1, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, GPR35, GSK3B, HCAR2, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT |
5.60999 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, APP, ATP1A1, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, KIT, MET, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
4.51742 |
[CC] GO:0045121 |
membrane raft
|
APP, ATP1A1, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
4.50583 |
[CC] GO:0098857 |
membrane microdomain
|
APP, ATP1A1, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
4.48452 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, ATP1A1, CA2, CA4, CA9, EGFR, TEK |
4.10895 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA4, DRD1, DRD2, DRD3, DRD5, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
3.98349 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX5, ALPL, APP, ATP1A1, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP2, PIM1, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR |
3.92208 |
[CC] GO:0098589 |
membrane region
|
APP, ATP1A1, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
3.87142 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, ATP1A1, CA2, CA4, CA9, DRD1, DRD2, DRD5, EGFR, INSR, MET, PTGS2, SRC, TEK |
3.2585 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
3.15632 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA2, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, TYR, XDH |
2.93576 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, APP, ATP1A1, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KCNH2, KDR, KIT, MET, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TEK, TYR |
2.93576 |
[CC] GO:0005783 |
None
|
ADORA1, APP, ATP1A1, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, HSPA1A, KDR, PTGS2, PTPN1, XDH |
2.89235 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, ATP1A1, AURKB, CA1, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, HSPA1A, IDO1, INSR, KCNH2, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, STAT3, TERT, TYR, XDH |
2.76869 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC |
2.69959 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA2, CA4, CA9, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, TYR, XDH |
2.63962 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD1, EGFR, FLT3, HSD11B1, HSD17B2, PTGS2, PTPN1 |
2.60815 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, KCNH2, MET, SLC6A2, TEK |
2.54225 |
[CC] GO:0005901 |
caveola
|
ATP1A1, INSR, PTGS2, SRC |
2.17349 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD11B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, TYR, XDH |
2.14549 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.119 |
[CC] GO:0097730 |
None
|
DRD1, DRD2, DRD5 |
2.05146 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, APP, ATP1A1, AURKB, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GSK3B, HSPA1A, IGF1R, KDR, KIT, MMP12, MMP2, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, STAT3, TERT, TYR, XDH |
2.03322 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
13.6928 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
13.3593 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, ATP1A1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DUSP3, EGFR, F3, FLT3, FUT7, GSK3B, HSD11B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TERT, TYR, XDH |
11.1006 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.1161 |
[MF] GO:0008144 |
drug binding
|
ACHE, ATP1A1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SLC6A4, SRC, TEK |
9.67735 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, ESRRA, ESRRB, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
8.94659 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.8195 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
8.23242 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
7.98604 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, SMAD3, STAT3, TEK |
7.74477 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
7.2813 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, KIT, MET, PPARA, RORC, TEK |
7.01809 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, HSD11B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
6.89154 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, STAT3 |
6.67703 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, STAT3 |
6.67703 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, ATP1A1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
6.40387 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.3383 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, IDO1, PTGS2, SRC |
6.3329 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.23722 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
6.2255 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, TYR |
6.08302 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, IDO1, PTGS2, SRC |
6.08164 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
5.93404 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, PTGS2, TYR |
5.69721 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
5.67439 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, XDH |
5.58831 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.49577 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
5.42677 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.37504 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.37504 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.11093 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, ATP1A1, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GSK3B, HSPA1A, KCNH2, KIT, MET, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, STAT3, TEK |
5.08134 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
5.05779 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, KIT, MET, MMP9, PTGS2, SLC6A4, SMAD3, STAT3, TERT, TYR, XDH |
5.02003 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.96286 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC |
4.90556 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.85922 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.79998 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.72655 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.50583 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
4.32792 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
4.32792 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, DRD5, SLC6A4 |
4.31144 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TERT |
4.28908 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, IDO1, PTGS2, SRC, XDH |
4.27612 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, ATP1A1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
4.27612 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.09258 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD11B1, HSD17B2, XDH |
3.96035 |
[MF] GO:0005496 |
steroid binding
|
ATP1A1, ESR1, ESR2, ESRRA, ESRRB, RORC |
3.96035 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, DRD2, FLT3, KCNH2, KIT, PTGS2, SLC6A4, SMAD3, STAT3, TERT, TYR, XDH |
3.59952 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.45219 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
ATP1A1, AXL, IGF1R, INSR |
3.42645 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.1997 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AXL, DRD2, EGFR, FLT3, KCNH2, KIT, PTGS2, SLC6A4, SMAD3, STAT3, TERT, TYR, XDH |
3.19059 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19, CYP2D6 |
3.17784 |
[MF] GO:0019900 |
None
|
ADRA2A, ATP1A1, AURKB, CDC25B, DUSP3, EGFR, ESR1, GSK3B, PTPN1, SMAD3, SRC, STAT3 |
3.08665 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
3.0798 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
3.05266 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.05266 |
[MF] GO:0035259 |
None
|
FLT3, SMAD3, STAT3 |
3.01487 |
[MF] GO:0019901 |
None
|
ADRA2A, ATP1A1, CDC25B, DUSP3, EGFR, ESR1, GSK3B, PTPN1, SMAD3, SRC, STAT3 |
2.93913 |
[MF] GO:0042562 |
hormone binding
|
ACHE, ATP1A1, EGFR, IGF1R, INSR |
2.89382 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, SMAD3, SRC, STAT3 |
2.83457 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.66277 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.66277 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.66277 |
[MF] GO:0019902 |
phosphatase binding
|
EGFR, MET, PPARA, PTPN1, SMAD3, STAT3 |
2.61447 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.53999 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, ATP1A1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, STAT3, TEK, TERT, XDH |
2.52266 |
[MF] GO:0005524 |
ATP binding
|
ATP1A1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.49701 |
[MF] GO:0008289 |
lipid binding
|
ATP1A1, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, PPARA, RORC |
2.4402 |
[MF] GO:0001588 |
None
|
DRD1, DRD5 |
2.42645 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.42645 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.42645 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.42645 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, ATP1A1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.42366 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ATP1A1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.39665 |
[MF] GO:0001085 |
RNA polymerase II transcription factor binding
|
ESR1, GSK3B, PPARA, SMAD3, STAT3 |
2.37722 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ATP1A1, AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
2.36911 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD11B1, HSD17B2 |
2.33015 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.32832 |
[MF] GO:0008134 |
transcription factor binding
|
ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, SMAD3, SRC, STAT3, TERT |
2.29102 |
[MF] GO:0005102 |
receptor binding
|
ADORA1, ADRA2A, APP, DRD2, DRD3, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, PTPN1, SMAD3, SRC, STAT3 |
2.28857 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, KIT, SMAD3 |
2.28857 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.25646 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.25646 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.25646 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.25646 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD17B2 |
2.22172 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.22172 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.19408 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD17B2 |
2.14464 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, ATP1A1, AURKB, AXL, CSNK2A1, DHFR, EGFR, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.12206 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, ATP1A1, CA1, CA2, CDC25B, CES1, CES2, DUSP3, PTPN1 |
2.119 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A4 |
2.119 |
[MF] GO:0055131 |
None
|
HSPA1A, KCNH2 |
2.119 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.119 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.119 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.119 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.08584 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.06034 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, ATP1A1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.00951 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.00951 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
EGFR, ESR1 |
2.00951 |
[MF] GO:0001758 |
None
|
AKR1B10, AKR1C3 |
2.00951 |
[MF] GO:0004032 |
None
|
AKR1B1, AKR1C3 |
2.00951 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.00951 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, ATP1A1, AURKB, AXL, CSNK2A1, DHFR, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.00951 |